Premium
Degarelix lowers risk of sexual abuse in men with pedophilic disorder
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30605
Subject(s) - medicine , sexual abuse , placebo , poison control , suicide prevention , medical emergency , alternative medicine , pathology
Men with pedophilic disorder who received injections of the gonadotropin‐releasing hormone (GnRH) antagonist degarelix acetate showed a significantly reduced risk score for committing child sexual abuse at 2 weeks, a placebo‐controlled trial has found. The results indicate potential for using GnRH antagonists as a rapidly acting preventive intervention for men with pedophilic disorder.